Cost-effectiveness of cognitive–behavioral therapy for depression: current evidence and future research priorities

References

• Greenberg P, Leong S, Birnbaum H. Cost of depression: current assessment and future directions. Expert Rev Pharmacoeconomics Outcomes Res. 1,69–76 (2001).
   PubMedGoogle Scholar
• Priest R, Vize C, Roberts A, Roberts M, Tylee A. Lay people's attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. BE Med. 313,858–859 (1996).
   PubMed Web of Science ®Google Scholar
• Seligman M. The effectiveness of psychotherapy: the consumer reports study. Am. fiychol. 50,965–974 (1995).
   PubMed Web of Science ®Google Scholar
• Department of Health. Treatment Choke in fiychological Therapies and Counselling: Evidence based clinical practice guideline. Department of Health, London, UK (2001).
   Google Scholar
• ••Review of the clinical effectiveness of psychological therapies, including CBT.
   Google Scholar
• Caftan E, Tsaousis I, Kemp-Wheeler S. Researcher allegiance and meta-analysis: the case of cognitive therapy for depression. Consult. Clin. PTchol. 63, 966–980 (1995).
   Google Scholar
• Harrington R, Whittaker J, Shoebridge P, Campbell E Systematic review of efficacy of cognitive-behaviour therapies in childhood and adolescent depressive disorder. BE Med. J316, 1559–1563 (1998).
   PubMed Web of Science ®Google Scholar
• Holmes J. All you need is cognitive— behaviour therapy. BE Med. 1. 324, 288–290 (2002).
   Google Scholar
• Andrews G. Talk that works: the rise of cognitive behaviour therapy. BE Med. J. 313, 1501–1502 (1996).
   PubMed Web of Science ®Google Scholar
• Chambless D, Hollon S. Defining empirically supported therapies. J. Consult. Clin. Psycho" 66, 7–18 (1998).
   Google Scholar
• •Review of the key issues in the evaluation of psychological therapies.
   Google Scholar
• Drummond M, Stoddart G, Torrance G. Methods for the Economic Evaluation of Healthcare Programmes Oxford Medical Publications, Oxford, UK (1997).
   Google Scholar
• Jacobson N, Dobson K, Truax P eta]. A component analysis of cognitive—behavioural treatment for depression. Consult. Clin. Psycho" 64, 295–304 (1996).
   Google Scholar
• King M, Davidson 0, Taylor F, Haines A, Sharp D, Turner R. Effectiveness of teaching general practitioners skills in brief cognitive behaviour therapy to treat patients with depression: randomised controlled trial. BE Med. 1. 324, 947–952 (2002).
   Google Scholar
• Hunkeler E, Meresman J, Hargreaves W eta]. Efficacy of nurse telehealthcare and peer support in augmenting treatment of depression in primary care. Arch. Fain. Med. 9, 700–708 (2000).
   Google Scholar
• Scott C, Scott J, Tacchi M, Jones R. Abbreviated cognitive therapy for depression: a pilot study in primary care. Behav. Cognit. PTchother 22, 57–64 (1994).
   Google Scholar
• Rush A, Watkins J. Group versus individual cognitive therapy: a pilot study. Cognit. Ther. Res. 5, 95–103 (1981).
   Web of Science ®Google Scholar
• Katon W, Robinson P, Von Korff M et al. A multifaceted intervention to improve treatment of depression in primary care. Arch. Gen. Psychiatry 53, 924–932 (1996).
   Google Scholar
• Lovell K, Richards D. Multiple access points and levels of entry (MAPLE): ensuring choice, accessibility and equity for CBT Services. Behav. Cognit. Psychother. 28, 379–391 (2000).
   Google Scholar
• ••Description of a model of care usingminimal intervention versions of CBT.
   Google Scholar
• White J. `Stresspac': three year follow-up of a controlled trial of a self help package for the anxiety disorders. Behav Cognit. PTchother. 26, 133–141 (1998).
   Google Scholar
• Cuijpers P Bibliotherapy in unipolar depression: a meta-analysis. J. Behav Ther. Exp. Fiychiatry 28, 139–147 (1997).
   Google Scholar
• White J, Jones R, McGarry E. Interactive treatment in primary care: can computers provide 'real' therapy? Clin. PTchol. Forum 131, 17–20 (1999).
   Google Scholar
• Schulberg H, Block M, Madonia M etal The 'Usual Care' of major depression in primary care practice. Arrh. Fain. Med. 6, 334–339 (1997).
   PubMedGoogle Scholar
• Elkin I, Shea T, Watkins J etal National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arrh. Gen PTchiatry 46, 971–982 (1989).
   PubMed Web of Science ®Google Scholar
• Paykel E, Scott J, Teasdale J etal Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch. Gen. Psychiatry 56, 829–835 (1999).
   PubMed Web of Science ®Google Scholar
• Lave J, Frank R, Schulberg H, Kamlet M. Cost-effectiveness of treatments for major depression in primary care practice. Arch. Gen. Psychiatry 55, 645–651 (1998).
   PubMed Web of Science ®Google Scholar
• Ward E, King M, Lloyd M et al Randomised controlled trial of non-directive counselling, cognitive—behaviour therapy and usual GP care for patients with depression. I: Clinical effectiveness. BE Med 321, 1383–1388 (2000).
   PubMed Web of Science ®Google Scholar
• Williams J, Barrett J, Oxman T etal Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JA/V/A 284, 1519–1526 (2000).
   Google Scholar
• Selmi P, Klein M, Greist J, Sorrell S, Erdman H. Computer administered cognitive—behavioural therapy for depression. AinJ PTchiatry147, 51–56 (1990).
   Google Scholar
• Howard K, Kopta S, Krause M, Orlinsky D. The dose—effect relationship in psychotherapy. Am. Fiychol. 41, 159–164 (1986).
   PubMed Web of Science ®Google Scholar
• Knapp M, Healey A. Psychotherapy: individual differences in costs and outcomes. In: Cost-effectiveness of Psychotherapy: A guide for practitioners, researchers and policy makers: Miller N, Magruder K (Eds), Oxford University Press, New York, NY, USA, 122–133 (1999).
   Google Scholar
• Lave J, Schulberg H. Integrating cost- effectiveness analyses within clinical trials of treatment for major depression in primary- care practice. In: Cost-effectiveness of Psychotherapy: A guide for practitioners, researchers and policy makers. Miller N, Magruder K (Eds). Oxford University Press, New York, NY, USA, 75–84 (1999).
   Google Scholar
• •Guide to the key issues involved in integrating cost-effectiveness studies into psychological therapy trials.
   Google Scholar
• Young J, Beck A. Cognitive Therapy Scale: Rating- Manual Unpublished manuscript (1980).
   Google Scholar
• Prescott R, Counsell C, Gillespie W etal Factors that limit the quality, number and progress of randomised controlled trials. Health Technol. Assess. 3 (1999).
   Google Scholar
• Roland M, Torgerson D. What are pragmatic trials? BE Med J316, 285 (1998).
   PubMed Web of Science ®Google Scholar
• Katon W, Von Korff M, Lin E etal Population-based care of depression: effective disease management strategies to decrease prevalence. Gen. Hosp. Psychiatry 19, 169–178 (1997).
   PubMed Web of Science ®Google Scholar
• Paykel E, Scott J, Teasdale J etal Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch. Gen. Psychiatry 56, 829–835 (1999).
   PubMed Web of Science ®Google Scholar
• Jarrett R, Kraft D, Doyle J, Foster B, Eaves G, Silver P Preventing recurrent depression using cognitive therapy with and without a continuation phase. Arch. Gen Psychiatry 58, 381–388 (2001).
   PubMed Web of Science ®Google Scholar
• Robson MET, France R, Bland M. Clinical psychologist in primary care: controlled clinical and economic evaluation. BE Med. 1. 288, 1805–1808 (1984).
   Google Scholar
• Scott A, Freeman C. Edinburgh primary care depression study: treatment outcome, patient satisfaction and cost after 16 weeks. Br. Med 304, 883–887 (1992).
   Google Scholar
• Bower P, Byford S, Sibbald B etal Randomised controlled trial of non-directive counselling, cognitive—behaviour therapy and usual GP care for patients with depression. II: Cost effectiveness. BE Med. 1. 321, 1389–1392 (2000).
   Google Scholar
• ••Cost-effectiveness study of CBT versusanother psychological therapy and usual care.
   Google Scholar
• Briggs A. Economic evaluation and clinical trials: size matters. BE Med 321, 1362–1363 (2000).
   PubMed Web of Science ®Google Scholar
• Von Korff M, Katon W, Bush T etal Treatment costs, cost offset and cost effectiveness of collaborative management of depression. Rychosom. Med. 60, 143–149 (1998). Press, New York, NY, USA, 85–98 (1999).
   Google Scholar
• •Cost-effectiveness study of a complex intervention in mental health utilizing CBT as part of the intervention.
   Google Scholar
• Schoenbaum M, Unutzer J, Sherboume C et al Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. /AIWA 286,1325–1330 (2001).
   PubMed Web of Science ®Google Scholar
• Sherboume C, Wells K, Duan N eta]. Long-term effectiveness of disseminating quality improvement for depression in primary care. Arch. Gen. Psychiatry 58, 696–703 (2001).
   Google Scholar
• Wells K, Sherboume C, Schoenbaum M et al Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAIVIA 283,212–220 (2000)
   PubMed Web of Science ®Google Scholar
• Antonuccio D, Thomas M, Danton W A cost-effectiveness analysis of cognitive—behaviour therapy and fluoxetine (Prozacl in the treatment of depression. Behaviour Therapy28, 187–210 (1997).
   Web of Science ®Google Scholar
• •Modeling study comparing cost-effectiveness of CBT and medication.
   Google Scholar
• Hargreaves W, Shumway M, Hu T Measuring psychotherapy cost and effectiveness. In: Cost-effectiveness of fiychotherapy: A guide for practitioners, researchers and policy makers. Miller N,
   Google Scholar
• Kamlet M and Kleinman L. Assessing the cost-utility of Psychotherapy. In: Cost-effectiveness of fiychotherapy: A guide for practitioners, researchers and policy makers. Miller N, Magruder K (Eds), Oxford University Press, New York, NY, USA, 99–108 (1999).
   Google Scholar
• Sobell M, Sobell L. Stepped care as a heuristic approach to the treatment of alcohol problems. j Consult. Clin. Psycho" 68,573–579 (2000).
   Google Scholar
• ••Introduction to the 'stepped care' model oftreatment provision.
   Google Scholar
• Adams M, McCall N, Gray D, Orza M, Chalmers T Economic analysis in randomized control trials. Med. Care 30, 231–243 (2002).
   Google Scholar
• Johnston K, Buxton M, Jones D, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 3 (1999).
   Google Scholar
• Gray A, Marshall M, Lockwood A, Morris J. Problems in conducting economic evaluations alongside clinical trials. Lessons from a study of case management for people with mental disorders. Br. Psychiatry 170,47–52 (1997).
   Google Scholar
• Beck A, Steer R. Beck Depression Inventory: manual. Psychological Corp., San Antonio, TX, USA (1987).
   Google Scholar
• EuroQol Group. EuroQol — a new facility for the measurement of health related quality of life. Health Policy 16,199–208 (1990).
   PubMed Web of Science ®Google Scholar
• Churchill R, Khaira M, Gretton V etal Treating depression in general practice: factors affecting patients' treatment preferences. Br j Gen. Pract. 50,905–906 (2000).
   PubMed Web of Science ®Google Scholar
• Chilvers C, Dewey M, Fielding K etal Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BE Med. 1 322,772–775 (2001).
   Google Scholar